Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 53.32B 7.89B 6.86B 6.39B 5.86B 11.07B 753B 11.24B 75.28B 29.55B 375B 29.64B 28.99B 1,258B | P/E 2026 * |
39.2x | P/E 2027 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.27B 7.15B 6.21B 5.78B 5.31B 10.02B 682B 10.18B 68.15B 26.75B 340B 26.84B 26.25B 1,139B | EV / Sales 2026 * |
5.97x | EV / Sales 2027 * | 5.04x |
| Free-Float |
61.14% | Yield 2026 * |
0.96% | Yield 2027 * | 1.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 07/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 19/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 18/07/2011 |
Hao Hong
CHM | Chairman | 70 | 07/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 18/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.89B | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | |
| Average | -1.19% | -1.21% | +26.03% | +42.41% | 379.88B | |
| Weighted average by Cap. | -1.00% | -2.02% | +36.14% | +71.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.08B 1.2B 1.04B 968M 889M 1.68B 114B 1.7B 11.41B 4.48B 56.85B 4.49B 4.39B 191B | 9.7B 1.44B 1.25B 1.16B 1.07B 2.02B 137B 2.05B 13.7B 5.38B 68.26B 5.39B 5.28B 229B |
| Net income | 1.4B 208M 180M 168M 154M 291M 19.81B 296M 1.98B 777M 9.86B 779M 762M 33.08B | 1.77B 262M 228M 212M 194M 367M 24.98B 373M 2.5B 980M 12.44B 983M 961M 41.71B |
| Net Debt | -5.05B -748M -650M -605M -555M -1.05B -71.36B -1.06B -7.13B -2.8B -35.53B -2.81B -2.75B -119B | -4.39B -650M -565M -526M -483M -912M -62.07B -926M -6.2B -2.43B -30.9B -2.44B -2.39B -104B |
| Date | Price | Change |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
